Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT).
Stroes CI, Schokker S, Khurshed M, van der Woude SO, Mathôt RA, Slingerland M, de Vos-Geelen J, Zucchetti M, Matteo C, van Dijk E, Ylstra B, Thijssen V, Derks S, Godefa T, Dijksterhuis W, Breimer GE, van Delden OM, Verhoeven RH, Meijer SL, Bijlsma MF, van Laarhoven HW. Stroes CI, et al. Ther Adv Med Oncol. 2022 Jun 28;14:17588359221109196. doi: 10.1177/17588359221109196. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35782751 Free PMC article.
Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.
van Erning FN, Mackay TM, van der Geest LGM, Groot Koerkamp B, van Laarhoven HWM, Bonsing BA, Wilmink JW, van Santvoort HC, de Vos-Geelen J, van Eijck CHJ, Busch OR, Lemmens VE, Besselink MG; Dutch Pancreatic Cancer Group. van Erning FN, et al. Acta Oncol. 2018 Dec;57(12):1655-1662. doi: 10.1080/0284186X.2018.1518593. Epub 2018 Sep 28. Acta Oncol. 2018. PMID: 30264642
Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study.
Dijksterhuis WPM, Verhoeven RHA, Slingerland M, Haj Mohammad N, de Vos-Geelen J, Beerepoot LV, van Voorthuizen T, Creemers GJ, van Oijen MGH, van Laarhoven HWM. Dijksterhuis WPM, et al. Int J Cancer. 2020 Apr 1;146(7):1889-1901. doi: 10.1002/ijc.32580. Epub 2019 Aug 24. Int J Cancer. 2020. PMID: 31340065 Free PMC article.
Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma.
Latenstein AEJ, van der Geest LGM, Bonsing BA, Groot Koerkamp B, Haj Mohammad N, de Hingh IHJT, de Meijer VE, Molenaar IQ, van Santvoort HC, van Tienhoven G, Verheij J, Vissers PAJ, de Vos-Geelen J, Busch OR, van Eijck CHJ, van Laarhoven HWM, Besselink MG, Wilmink JW; Dutch Pancreatic Cancer Group. Latenstein AEJ, et al. Eur J Cancer. 2020 Jan;125:83-93. doi: 10.1016/j.ejca.2019.11.002. Epub 2019 Dec 13. Eur J Cancer. 2020. PMID: 31841792 Free article.
Trends in treatment and overall survival among patients with proximal esophageal cancer.
de Vos-Geelen J, Geurts SM, van Putten M, Valkenburg-van Iersel LB, Grabsch HI, Haj Mohammad N, Hoebers FJ, Hoge CV, Jeene PM, de Jong EJ, van Laarhoven HW, Rozema T, Slingerland M, Tjan-Heijnen VC, Nieuwenhuijzen GA, Lemmens VE. de Vos-Geelen J, et al. World J Gastroenterol. 2019 Dec 21;25(47):6835-6846. doi: 10.3748/wjg.v25.i47.6835. World J Gastroenterol. 2019. PMID: 31885424 Free PMC article.
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study.
Dijksterhuis WPM, Verhoeven RHA, Meijer SL, Slingerland M, Haj Mohammad N, de Vos-Geelen J, Beerepoot LV, van Voorthuizen T, Creemers GJ, van Oijen MGH, van Laarhoven HWM. Dijksterhuis WPM, et al. Gastric Cancer. 2020 Jul;23(4):579-590. doi: 10.1007/s10120-020-01039-7. Epub 2020 Jan 11. Gastric Cancer. 2020. PMID: 31927675 Free PMC article.
Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis.
Latenstein AEJ, Mackay TM, Creemers GJ, van Eijck CHJ, de Groot JWB, Haj Mohammad N, Homs MYV, van Laarhoven HWM, Molenaar IQ, Ten Tije BJ, de Vos-Geelen J, Besselink MG, van der Geest LGM, Wilmink JW; Dutch Pancreatic Cancer Group. Latenstein AEJ, et al. Acta Oncol. 2020 Jun;59(6):705-712. doi: 10.1080/0284186X.2020.1725241. Epub 2020 Feb 14. Acta Oncol. 2020. PMID: 32056483
A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer.
de Vos-Geelen J, Hoebers FJP, Geurts SME, Hoeben A, de Greef BTA, Voncken FEM, Bogers JHA, Braam PM, Muijs CKT, de Jong MA, Kasperts N, Rozema T, Jeene PM, Blom GJ, van Dieren JM, Hulshof MCCM, van Laarhoven HWM, Grabsch HI, Lemmens VEPP, Tjan-Heijnen VCG, Nieuwenhuijzen GAP. de Vos-Geelen J, et al. Acta Oncol. 2020 Aug;59(8):895-903. doi: 10.1080/0284186X.2020.1753889. Epub 2020 Apr 22. Acta Oncol. 2020. PMID: 32319845 Free article.
Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study.
Dijksterhuis WPM, Verhoeven RHA, Pape M, Slingerland M, Haj Mohammad N, de Vos-Geelen J, Beerepoot LV, van Voorthuizen T, Creemers GJ, Lemmens VEPP, van Oijen MGH, van Laarhoven HWM. Dijksterhuis WPM, et al. Eur J Cancer. 2020 Nov;139:107-118. doi: 10.1016/j.ejca.2020.08.010. Epub 2020 Sep 25. Eur J Cancer. 2020. PMID: 32980749 Free article.
Relationship Between Quality of Life and Survival in Patients With Pancreatic and Periampullary Cancer: A Multicenter Cohort Analysis.
Mackay TM, Latenstein AEJ, Sprangers MAG, van der Geest LG, Creemers GJ, van Dieren S, de Groot JB, Groot Koerkamp B, de Hingh IH, Homs MYV, de Jong EJM, Molenaar IQ, Patijn GA, van de Poll-Franse LV, van Santvoort HC, de Vos-Geelen J, Wilmink JW, van Eijck CH, Besselink MG, van Laarhoven HWM; Dutch Pancreatic Cancer Group. Mackay TM, et al. J Natl Compr Canc Netw. 2020 Oct 1;18(10):1354-1363. doi: 10.6004/jnccn.2020.7579. Print 2020 Oct. J Natl Compr Canc Netw. 2020. PMID: 33022643
105 results